By Dr. Evan Lewis, MD
Toenail fungus is one of the most common conditions presented to podiatrists — and one of the most frustrating to treat. Not because effective options do not exist, but because the nail grows slowly, treatment requires months of consistent application, and patients face a range of options with genuinely different tradeoff profiles depending on their situation.
This article is for patients. If you have seen — or are considering seeing — a podiatrist for toenail fungus, here is what the conversation will typically cover: the three main clinical approaches, what the evidence says about each one, how the compliance question shapes real-world outcomes, and what questions are worth bringing to your appointment.
Why Toenail Fungus Is So Common
Onychomycosis — the clinical term for fungal nail infection — affects an estimated 10 to 15 percent of the general population. That number climbs substantially in specific groups: adults over 60, where rates may exceed 20 percent; athletes and people with frequent exposure to communal changing environments; and people with diabetes or conditions affecting circulation and immune response.
The reason the condition is so prevalent is partly biological and partly behavioural. Dermatophyte fungi — the organism responsible for the majority of toenail infections — thrive in the warm, moist, enclosed environments that enclosed footwear creates. Fungal spores persist on shared surfaces: gym floors, pool surrounds, locker room floors, communal showers. The nail itself provides a protected environment where fungal organisms can establish without being easily reached by topical treatments.
Behavioural patterns matter equally. Toenail fungus is rarely painful in its early stages, which means many people live with it for years before seeking treatment. By the time it presents to a podiatrist, the infection may be well-established across multiple nails and have been present for 2 to 5 years. This is not exceptional — it is the most common presentation pattern podiatrists see.
The Three Clinical Approaches Podiatrists Discuss
Option 1: Oral Antifungals (Terbinafine / Lamisil)
Oral antifungal therapy — most commonly terbinafine, marketed as Lamisil — is the highest-efficacy option currently available for toenail fungus. It is what most patients receive when a podiatrist is treating a moderate to severe infection and wants the best available cure rate.
How it works: Terbinafine is a systemic antifungal. Taken as a daily pill, it is absorbed through the gastrointestinal tract and reaches the nail through the bloodstream — specifically, through the nail matrix, where new nail grows. This systemic delivery allows it to reach the fungal organisms inside the nail in a way that topical treatments struggle to achieve through an intact nail plate.
Effectiveness: Oral terbinafine achieves mycological cure rates (laboratory-confirmed clearance of the fungal organism) of approximately 70 to 80 percent in clinical trials. This is meaningfully higher than topical alternatives. For patients with moderate to severe infections across multiple nails, it is the strongest available option.
Duration: A standard course for toenail infections is 90 days — 12 weeks of daily pills. This is the duration that achieves the clinical evidence rates above.
Downsides and considerations: Oral terbinafine is not appropriate for all patients. It requires liver function tests before and sometimes during treatment because the drug is metabolised through the liver, and rare cases of hepatotoxicity have been reported. It has interactions with several common medications. It is not recommended during pregnancy or for patients with existing liver conditions. GI side effects — nausea, abdominal discomfort — occur in a subset of patients. For patients without contraindications, it is well-tolerated and effective; the screening process exists because the small percentage of patients for whom it is not appropriate need to be identified.
Option 2: Prescription Topicals (Jublia / Efinaconazole; Penlac / Ciclopirox)
For patients who cannot take oral antifungals, or who prefer to start with a topical approach, prescription-strength topicals are the next clinical tier.
How they work: Prescription antifungal topicals are applied directly to the nail surface and penetrate the nail plate to reach fungal organisms below. Jublia (efinaconazole 10%) uses a formulation designed to penetrate the nail better than earlier topical antifungals. Penlac (ciclopirox) uses a lacquer vehicle that builds up on the nail surface over time.
Effectiveness: Jublia's pivotal clinical trials showed mycological cure rates of approximately 45 to 55 percent at 52 weeks. This is meaningfully lower than oral terbinafine's 70 to 80 percent, but achieved without systemic drug exposure — an important tradeoff for patients for whom oral antifungals are contraindicated or undesirable.
Duration: 48 weeks of daily application. Nearly a full year of consistent, daily nail painting. Compliance across that duration is a real challenge, particularly because visible improvement can take months and there is no day-to-day sensory feedback that the treatment is working.
Cost: This is the most significant practical barrier. Without insurance coverage, Jublia costs $600 to $900 per bottle in Canada. It requires a prescription, which requires a podiatrist or dermatologist visit. For patients without coverage, the cost barrier is prohibitive for many.
Option 3: OTC and Natural Options, Including Aqueous Iodine
For mild to moderate infections — and increasingly as a starting point before escalating to prescription options — many patients discuss over-the-counter and natural alternatives with their podiatrists. Among these, aqueous iodine has the strongest evidence base.
Three published studies support aqueous iodine for onychomycosis:
A study published in the Journal of Family Practice (PMC1569938) examined decolorized aqueous iodine applied to nails with onychomycosis, with daily application consistent with the regimens used in current products. The study demonstrated significant clinical improvement in the treatment group. This is the foundational clinical reference for aqueous iodine in fungal nail care.
Research indexed at PMC4599634 examined iodine-based formulations — specifically povidone-iodine combined with DMSO as a penetration enhancer — demonstrating clinical improvement in fungal nail infections. This study contributes to understanding how iodine-based agents reach their target beneath the nail plate.
A study in the Journal of the American Academy of Dermatology (JAAD S0190-9622(14)00459-9) examined a topical iodine nail solution and confirmed activity against dermatophytes — the fungal organisms responsible for the majority of onychomycosis cases. This extends the evidence beyond clinical outcome studies to in vitro confirmation of mechanism.
How aqueous iodine works: Iodine disrupts fungal cell membranes through oxidative damage and interferes with the protein structures essential to fungal cell function. Unlike azole antifungals, which target a specific enzyme (lanosterol 14α-demethylase), iodine works through multiple simultaneous mechanisms — which is associated with low resistance potential. Fungal organisms have not demonstrated significant resistance to iodine in over 150 years of clinical use.
Cost and accessibility: Aqueous iodine formulations like IodinePure EZ Clear Nails are available without a prescription and at a fraction of the cost of Jublia. No clinic visit is required to begin treatment.
Best suited for: Mild to moderate nail fungus as a first-line daily treatment; patients who prefer to avoid medications; patients without insurance coverage for prescription topicals; as a preventive and maintenance protocol following prescription treatment. For moderate to severe or persistent infections, a podiatrist conversation about prescription options remains important.
The Compliance Question
Across all three treatment options, the variable with the largest real-world impact on outcomes is often not the treatment itself — it is compliance.
The nail grows at approximately 3 mm per month. An infected nail requires full regrowth from the nail matrix outward before a visibly clear nail emerges — a process that takes 9 to 12 months for a toenail. No treatment eliminates the fungus and visually clears the nail in weeks. Every treatment option requires months of consistent daily application or ongoing therapy.
In clinical trials, compliance is controlled and monitored. In real life, it is the deciding variable. A treatment with a 55 percent efficacy rate used with 95 percent compliance will outperform a treatment with a 70 percent efficacy rate used with 40 percent compliance. This is the real-world reason cost and accessibility matter: a $900 treatment that creates a compliance barrier is not practically superior to an affordable daily protocol that a patient will actually maintain.
Whatever approach you choose — oral, prescription topical, or aqueous iodine protocol — the discipline of daily application, maintained consistently over 90 to 180 days, is the primary determinant of your outcome.
Questions to Ask Your Podiatrist
If you are seeing a podiatrist for toenail fungus, these questions help you understand your situation and make an informed decision:
- How severe is this infection? Which nails are involved, and to what degree?
- Based on the severity, what option do you recommend as a starting point?
- Am I a candidate for oral terbinafine? If not, why not?
- Would an aqueous iodine protocol be appropriate for my situation as a first-line or adjunct treatment?
- What would you expect to see as a sign that treatment is working, and at what point would we reassess?
Frequently Asked Questions
Should I see a podiatrist for toenail fungus?
For mild infections that are early-stage and affecting one nail, many people reasonably start with an over-the-counter protocol — including aqueous iodine — before seeking a podiatrist appointment. If the infection is moderate to severe, affects multiple nails, has been present for more than a year, or involves significant nail thickening or separation, a podiatrist visit provides assessment, confirmation of diagnosis, and access to prescription options that OTC approaches cannot offer. If you have diabetes or a condition affecting your immune system or circulation, see a podiatrist for any foot infection — do not self-treat.
What do podiatrists prescribe for nail fungus?
The most commonly prescribed options are oral terbinafine (Lamisil) for moderate to severe infections — 12 weeks of daily pills with the highest available cure rates — and prescription topicals including Jublia (efinaconazole 10%) and Penlac (ciclopirox) for patients for whom oral therapy is not suitable. The choice depends on infection severity, patient health history, contraindications, and patient preference. Many podiatrists also discuss and support daily aqueous iodine protocols as part of a comprehensive at-home approach, particularly for mild infections and as maintenance following prescription treatment.
Is iodine as effective as Jublia?
This is a fair and important question, and the honest answer is nuanced. Jublia's pivotal clinical trials show mycological cure rates of 45 to 55 percent at 52 weeks in controlled trial conditions. Aqueous iodine has three published studies demonstrating clinical improvement, but these studies were not powered or designed to produce head-to-head cure rate comparisons at the scale of pharmaceutical registration trials. It would not be accurate to claim that iodine achieves the same documented cure rate as Jublia. What can be said is that aqueous iodine has a genuine published evidence base, a well-understood mechanism of action, over 150 years of clinical safety data, and a cost and accessibility profile that makes consistent daily use achievable. These are meaningful advantages for a treatment where compliance is often the deciding factor.
Can I use iodine alongside prescription treatment?
Many patients do, and many podiatrists support this approach. Aqueous iodine and topical prescription antifungals work through different mechanisms and there are no known interactions between them. Some patients use prescription topicals for their clinical appointments while maintaining an aqueous iodine daily spray as part of their routine. Others use aqueous iodine as a preventive maintenance protocol after completing a course of oral terbinafine, to reduce the risk of reinfection. Discuss this with your podiatrist in the context of your specific situation.
How long does toenail fungus treatment take?
Regardless of which treatment option you choose, expect a minimum of 6 to 12 months before a visually clear nail emerges. The nail grows at approximately 3 mm per month. Even if treatment successfully addresses the fungal infection quickly, the previously infected nail tissue must physically grow out and be replaced by new, healthy nail from the matrix. Active treatment courses — oral terbinafine at 12 weeks, Jublia at 48 weeks, daily aqueous iodine for 90+ days — address the active infection, but visible nail clearance follows at the pace of nail growth regardless.
Start the 90-Day Protocol
IodinePure EZ Clear Nails delivers aqueous iodine — the formulation supported by three published studies — directly to the nail twice daily. No prescription required. Two ingredients. A clinically rational starting point while you assess your options.
Shop EZ Clear Nails — Start the 90-day iodine protocol. Three published studies support it.
